PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM
Retinal Vascular Changes in Treatment-Resistant Neovascular Age-Related Macular Degeneration Patients Treated With Aflibercept
Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)
RANZCO CLINICAL AUDIT TOOL (RCAT)